Born in 2010, SKYER develops and produces high quality and highly efficient antigen-antibody reaction test kits that have shown consistent sensitivity, specificity, and accuracy. And we will continue our effort to make faster and more accurate test kits by integrating advanced materials and technologies into our system. We believe rapid tests (also known as lateral flow assays - LFAs - or immunochromatographic strip tests - ICTs), especially in the POCT, are crucial for managing zoonotic pandemics with the lowest cost. We pursue creative ideas, open-mindedness, infinite opportunities, and diversity to create a world where humans and nature coexist safely.